Dr. Reimers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Summary
- I am a board certified medical oncologist specializing in genitourinary oncology. I primarily treat patients with prostate, bladder, and kidney cancers. My main research focus is in clinical trial development.
Education & Training
University of North Carolina HospitalsResidency, Internal Medicine, 2013 - 2016
Saint Louis University School of MedicineClass of 2013
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2019 - 2025
MI State Medical License 2016 - 2020
NC State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations Start of enrollment: 2018 Dec 14
- Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) Start of enrollment: 2021 Feb 19
- Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer Start of enrollment: 2024 Jun 04
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsUrine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.Pradeep S. Chauhan, Kevin Chen, Ramandeep K. Babbra, Wenjia Feng, Nadja Pejovic
Plos Medicine. 2021-08-31 - 2 citationsTumour evolution and microenvironment interactions in 2D and 3D space.Chia-Kuei Mo, Jingxian Liu, Siqi Chen, Erik Storrs, Andre Luiz N Targino da Costa
Nature. 2024-10-01 - 15 citationsEpigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Yige Wu, Nadezhda V Terekhanova, Wagma Caravan, Nataly Naser Al Deen, Preet Lal
Nature Communications. 2023-03-27
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
